Effects of a Holistic Yoga Program on Endocrine Parameters in Adolescents with Polycystic Ovarian Syndrome: A Randomized Controlled Trial
Authors:
- 1 February 2013
- journal article
- research article
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 19 (2) , 153-160
Abstract
Objectives: The objectives of this trial were to compare the effects of a holistic yoga program with the conventional exercise program in adolescent polycystic ovarian syndrome (PCOS). Design: This was a prospective, randomized, active controlled trial. Setting: Ninety (90) adolescent (15–18 years) girls from a residential college in Andhra Pradesh who satisfied the Rotterdam criteria were randomized into two groups. Intervention: The yoga group practiced a holistic yoga module, while the control group practiced a matching set of physical exercises (1 hour/day, for 12 weeks). Outcome measures: Anti-müllerian hormone (AMH-primary outcome), luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, prolactin, body–mass index (BMI), hirsutism, and menstrual frequency were measured at inclusion and after 12 weeks. Results: Mann-Whitney test on difference score shows that changes in AMH (Y=−2.51, C=−0.49, p=0.006), LH, and LH/FSH ratio (LH: Y=−4.09, C=3.00, p=0.005; LH/FSH: Y=−1.17, C=0.49, p=0.015) were significantly different between the two intervention groups. Also, changes in testosterone (Y=−6.01, C=2.61, p=0.014) and Modified Ferriman and Gallway (mFG) score (Y=−1.14, C=+0.06, p=0.002) were significantly different between the two groups. On the other hand, changes in FSH and prolactin postintervention were nonsignificantly different between the two groups. Also, body weight and BMI showed nonsignificantly different changes between the two groups, while changes in menstrual frequency were significantly different between the two groups (Y=0.89, C=0.49, p=0.049). Conclusions: A holistic yoga program for 12 weeks is significantly better than physical exercise in reducing AMH, LH, and testosterone, mFG score for hirsutism, and improving menstrual frequency with nonsignificant changes in body weight, FSH, and prolactin in adolescent PCOS.Keywords
This publication has 31 references indexed in Scilit:
- Prevalence of Polycystic Ovarian Syndrome in Indian AdolescentsJournal of Pediatric and Adolescent Gynecology, 2011
- Circadian variation in concentration of anti-Mullerian hormone in regularly menstruating females: relation to age, gonadotrophin and sex steroid levelsHuman Reproduction, 2011
- Prevalence of polycystic ovary syndrome in unselected women from southern ChinaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic OvariesThe Journal of Clinical Endocrinology & Metabolism, 2007
- Serum anti-müllerian hormone levels in women with secondary amenorrheaFertility and Sterility, 2006
- Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndromeHuman Reproduction, 2005
- Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular ArrestThe Journal of Clinical Endocrinology & Metabolism, 2003
- Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal womenFertility and Sterility, 2002
- Polycystic ovaries and associated clinical and biochemical features in young womenClinical Endocrinology, 1999
- Polycystic Ovary SyndromeNew England Journal of Medicine, 1995